Table II.
CDKN2A and/or TP53 alteration rate
| CDKN2A | TP53 | Either/Both* | |
|---|---|---|---|
| Alterations | 12 | 8 | 17 |
| Normal | 95 | 85 | 72 |
|
| |||
| Percentage | 11.20% | 8.60% | 19.10% |
*
two patients had both p16 loss and p53 mutation
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.